289 related articles for article (PubMed ID: 18987785)
1. Oxidative modification of LDL: its pathological role in atherosclerosis.
Itabe H
Clin Rev Allergy Immunol; 2009 Aug; 37(1):4-11. PubMed ID: 18987785
[TBL] [Abstract][Full Text] [Related]
2. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoproteins: what is understood and what remains to be clarified.
Itabe H
Biol Pharm Bull; 2003 Jan; 26(1):1-9. PubMed ID: 12520163
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells.
Itabe H; Takano T
J Atheroscler Thromb; 2000; 7(3):123-31. PubMed ID: 11480452
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
Boyd HC; Gown AM; Wolfbauer G; Chait A
Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
[TBL] [Abstract][Full Text] [Related]
7. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
Tsimikas S; Palinski W; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
Hulthe J
Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde.
Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK
Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571
[TBL] [Abstract][Full Text] [Related]
10. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL in carotid plaques and plasma associates with plaque instability.
Nishi K; Itabe H; Uno M; Kitazato KT; Horiguchi H; Shinno K; Nagahiro S
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1649-54. PubMed ID: 12377744
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis.
Cerne D; Jürgens G; Ledinski G; Kager G; Greilberger J; Lukac-Bajalo J
Clin Chem Lab Med; 2002 Jan; 40(1):15-20. PubMed ID: 11916265
[TBL] [Abstract][Full Text] [Related]
14. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
Shaw PX
Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
[TBL] [Abstract][Full Text] [Related]
15. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins.
Hammer A; Kager G; Dohr G; Rabl H; Ghassempur I; Jürgens G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):704-13. PubMed ID: 7749884
[TBL] [Abstract][Full Text] [Related]
16. The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions.
Itabe H; Kato R; Sawada N; Obama T; Yamamoto M
Curr Med Chem; 2019; 26(9):1576-1593. PubMed ID: 29521196
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
18. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
19. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein undergoes oxidative modification in vivo.
Palinski W; Rosenfeld ME; Ylä-Herttuala S; Gurtner GC; Socher SS; Butler SW; Parthasarathy S; Carew TE; Steinberg D; Witztum JL
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1372-6. PubMed ID: 2465552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
